Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration [Phase 1]
Phase 1 study comparing PK/PD of BIOD-123 and BIOD-125 with Humalog in people with Type 1 diabetes, including assessments of injection site …
-
CLINICAL_TRIALS research · 2013-07-23Clinical Trial Update: Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM) [Phase 1]
This is a Phase 1 clinical trial update evaluating cord blood infusion for Type 1 diabetes mellitus in children, sponsored by Technical Univ…
-
FDA approval · 2013-07-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2013-07-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: MDRS for Prevention of Nocturnal Hypoglycemia [Phase 1]
A Phase 1 study of MDRS for preventing nocturnal hypoglycemia in individuals with Type 1 diabetes mellitus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-07-16Clinical Trial Update: Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes. [NA]
This update discusses a clinical trial evaluating whether acute exercise affects endothelial function in patients with Type 1 diabetes melli…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating DiaPep277 in Type 1 Diabetes has completed and reports on long-term treatment effects.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: The Effects of Regular Home Use Vs Diabetic Team- Supported Use of the Medtronic CareLink Therapy Management System. [Phase 4]
Phase 4 clinical trial comparing regular home use versus diabetic team–supported use of the Medtronic CareLink Therapy Management System in …
-
CLINICAL_TRIALS research · 2013-06-28Clinical Trial Update: Metformin Therapy in Type 1 Diabetes Mellitus.
Clinical trial update examining metformin therapy in Type 1 diabetes mellitus to address loss of glycemic control.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes [Phase 2]
Phase 2 trial update for Zocor (simvastatin) and Vytorin (ezetimibe/simvastatin) in adolescents with Type 1 diabetes and dyslipidemia; study…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes [Phase 2, Phase 3]
A Phase 2/3 clinical trial update exploring autologous mesenchymal stem cell transplantation for onset of Type 1 diabetes, with status liste…
-
FDA approval · 2013-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. Thi…
-
FDA approval · 2013-06-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi-Aventis U.S. LLC.
-
FDA label_change · 2013-05-31FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-05-31FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-05-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action authorizes changes to the produ…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial evaluated metformin in overweight adults with dysregulated Type 1 Diabetes Mellitus. The study has completed.
-
FDA approval · 2013-05-16FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) by Sanofi U.S. LLC.
-
FDA approval · 2013-05-10FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company. The action approves changes un…
-
FDA approval · 2013-05-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro (Humalog) from Eli Lilly, marking an update to the product under the existing…
-
FDA approval · 2013-05-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Effects of Vitamin B1 in Type 1 Diabetic Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial investigated the effects of thiamine (Vitamin B1) in patients with Type 1 diabetes. The document …
-
CLINICAL_TRIALS withdrawal · 2013-05-08Clinical Trial Update: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [NA]
The trial evaluating a calcineurin inhibitor-free, steroid-free immunosuppressive regimen for simultaneous islet-kidney transplantation in u…
-
CLINICAL_TRIALS research · 2013-04-26Clinical Trial Update: Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes [NA]
This clinical trial update discusses hypoglycemia risk at the start of insulin pump therapy in children with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis [Phase 2]
Phase 2 trial update for TZP-102 evaluating treatment of symptoms in diabetic gastroparesis. Study status is completed.